Treatments such as retinal photocoagulation and intravitreal anti-vascular endothelial growth factor (VEGF) injections are effective in managing abnormal blood vessel growth [2], but no currently available treatments can truly treat ROP by restoring the retinal vascular networks that have already become avascular [1,2,3]. This evidence concerns the gene VEGFA and retinopathy of prematurity.